Skip to main content

Table 4 AUC and test characteristics of different androgens for representing hyperandrogenemia in PCOS patients using ROC analysis

From: Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS

Androgens

AUC

95% CI

Z value

P value

Optimal cutoff value of androgens

Sensitivity (95% CI)

Specificity (95% CI)

Positive predictive value (95% CI)

Negative predictive value (95% CI)

Positive LR (95% CI)

Negative LR (95% CI)

TT

0.816

0.742–0.876

8.894

< 0.001

0.337

72.0 (62.1–80.5)

82.93 (67.9–92.8)

91.1 (82.6–96.3)

54.8 (41.7–67.5)

4.22 (3.5–5.1)

0.34 (0.2–0.7)

AD

0.842

0.771–0.898

10.489

< 0.001

1.309

81.0 (71.9–88.2)

73.17 (57.1–85.8)

88.0 (79.6–93.9)

61.2 (46.2–74.8)

3.02 (2.5–3.7)

0.26 (0.1–0.3)

DHEA-S

0.678 ac

0.594–0.754

3.792

< 0.001

1887.057

86.0 (77.6–92.1)

48.78 (32.9–64.9)

80.4 (71.6–87.4)

58.8 (40.7–75.3)

1.68 (1.2–2.3)

0.29 (0.2–0.5)

FAI

0.937 bcd

0.883–0.971

22.389

< 0.001

2.50

87.0 (78.8–92.9)

92.68 (80.1–98.4)

96.7 (90.6–99.3)

74.5 (60.4–85.7)

11.89 (10.6–13.3)

0.14 (0.04–0.5)

  1. Compared with AUCTT, a: P < 0.01, b: P< 0.001
  2. Compared with AUCAD, c: P< 0.001
  3. Compared with AUCDHEA-S, d: P< 0.001